Between 60% and 78% of people diagnosed with irritable bowel syndrome test positive for small intestinal bacterial overgrowth. That single statistic explains why so many IBS patients cycle through dietary changes, fiber supplements, and antispasmodics without lasting relief. IBS and SIBO share the same headline symptoms, bloating, abdominal pain, diarrhea, and constipation, but they are fundamentally different conditions. IBS is a label applied when symptoms match a checklist and nothing else is found. SIBO is a specific, testable imbalance with identifiable causes and targeted treatments. Understanding where these two conditions overlap and where they diverge is the first step toward getting the right diagnosis.
What is IBS?
Irritable bowel syndrome is a functional gastrointestinal disorder defined by the Rome IV criteria. To receive an IBS diagnosis, a patient must have recurrent abdominal pain at least one day per week for the past three months, associated with two or more of the following: pain related to defecation, a change in stool frequency, or a change in stool form. Symptoms must have started at least six months before diagnosis. IBS is classified into subtypes: IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), IBS-M (mixed), and IBS-U (unsubtyped).
The critical point is that IBS is a diagnosis of exclusion. There is no blood test, imaging study, or biomarker that confirms IBS. The Rome IV criteria are symptom-based, and the diagnosis is made after ruling out other conditions like celiac disease, inflammatory bowel disease, and colorectal cancer. Notably, SIBO testing is not part of the standard IBS diagnostic workup in most clinical settings.
What is SIBO?
Small intestinal bacterial overgrowth is defined as an excessive number of bacteria in the small intestine, where the bacterial population is normally kept low by gastric acid, bile, the migrating motor complex (MMC), and the ileocecal valve. When these defenses fail, bacteria from the colon migrate upward or resident small intestinal bacteria multiply unchecked. These bacteria ferment carbohydrates that should be absorbed in the small intestine, producing hydrogen, methane, or hydrogen sulfide gas. The result is bloating, distension, pain, and altered bowel habits.
Unlike IBS, SIBO has a testable mechanism. Breath testing can detect the gases produced by overgrown bacteria. Jejunal aspirate culture can measure bacterial counts directly (though this is rarely done outside research). The 2017 North American Consensus defines positive SIBO as a hydrogen rise of 20 ppm or more above baseline within 90 minutes on a breath test, methane at 10 ppm or more at any point, or hydrogen sulfide at 3 ppm or more on a trio-smart test.
How do IBS and SIBO symptoms overlap?
The symptom overlap between IBS and SIBO is extensive, which is precisely why misdiagnosis is so common. Both conditions produce bloating (the most frequently reported symptom in both), abdominal pain or cramping, diarrhea, constipation, and excessive gas. Both can cause fatigue, brain fog, and food intolerances. A clinician looking only at a symptom list cannot distinguish one from the other.
| Symptom | IBS | SIBO |
|---|---|---|
| Bloating | Very common | Very common |
| Abdominal pain | Defining feature (Rome IV) | Common, often post-meal |
| Diarrhea | IBS-D subtype | Hydrogen-dominant SIBO |
| Constipation | IBS-C subtype | Methane/IMO-dominant SIBO |
| Excessive gas | Common | Common, often within 90 min of eating |
| Food intolerances | Common, variable triggers | Common, especially high-FODMAP foods |
| Nausea | Occasional | Common, especially post-meal |
| Fatigue/brain fog | Reported frequently | Reported frequently |
What are the key differentiators between IBS and SIBO?
Despite the symptom overlap, several clinical features point more strongly toward SIBO than uncomplicated IBS. None of these are definitive on their own, but when multiple indicators are present, SIBO testing becomes a high-value next step.
- Symptoms within 90 minutes of eating. In SIBO, bacteria begin fermenting food shortly after it reaches the small intestine, producing gas and bloating quickly. In IBS without SIBO, bloating may be more diffuse and less consistently tied to meals.
- Improvement with fasting. Because SIBO symptoms are driven by bacterial fermentation of food, many SIBO patients notice that symptoms decrease significantly during prolonged fasting (12+ hours). This pattern is less consistent in IBS driven by visceral hypersensitivity or motility issues alone.
- Post-food-poisoning onset. A clear history of gastroenteritis followed by the gradual development of IBS symptoms strongly suggests post-infectious SIBO. The Pimentel group has shown that food poisoning can trigger autoimmune damage to the interstitial cells of Cajal via anti-vinculin antibodies, impairing the MMC and allowing bacterial overgrowth.
- Response to rifaximin. Rifaximin (Xifaxan) is FDA-approved for IBS-D but works specifically by reducing bacterial load in the small intestine. If a patient improves on rifaximin but relapses after the course ends, that pattern strongly suggests underlying SIBO rather than IBS alone.
- Elevated breath test gases. A positive lactulose or glucose breath test provides objective evidence of bacterial overgrowth that symptom-based IBS criteria cannot capture.
âšī¸A post-food-poisoning onset is one of the strongest clinical predictors of SIBO. The ibs-smart blood test measures anti-vinculin and anti-CdtB antibodies to confirm the post-infectious mechanism. A positive result does not diagnose active SIBO directly but identifies the autoimmune motility damage that causes it.
How are IBS and SIBO diagnosed differently?
IBS is diagnosed clinically using the Rome IV criteria. The physician confirms that symptoms meet the frequency and duration thresholds, rules out red-flag conditions (celiac, IBD, colorectal cancer) with basic bloodwork and possibly a colonoscopy, and applies the IBS label. No test confirms IBS. It is what remains after other diagnoses have been excluded.
SIBO diagnosis requires a specific test. The lactulose breath test is the most commonly used option in clinical practice. The glucose breath test is an alternative with higher specificity but lower sensitivity. The trio-smart test adds hydrogen sulfide measurement. The ibs-smart blood test identifies the post-infectious autoimmune mechanism. In research settings, jejunal aspirate culture (positive at greater than 10^3 CFU/mL) serves as the reference standard but is rarely used clinically due to its invasive nature and contamination risk.
| Diagnostic Feature | IBS | SIBO |
|---|---|---|
| Diagnostic method | Symptom criteria (Rome IV) | Breath test, aspirate culture |
| Confirmatory test exists? | No | Yes |
| Requires ruling out other conditions? | Yes (diagnosis of exclusion) | No (positive test confirms) |
| Standard workup includes SIBO testing? | Usually no | N/A |
| Antibody testing available? | No | Yes (ibs-smart for post-infectious) |
How do treatment approaches differ?
IBS treatment is primarily symptom management. Standard recommendations include dietary modification (often a low-FODMAP diet), fiber supplementation, antispasmodics like hyoscyamine or dicyclomine, loperamide for diarrhea, and occasionally low-dose tricyclic antidepressants or SSRIs for pain modulation. These approaches aim to reduce symptoms without addressing a specific underlying cause.
SIBO treatment targets the bacterial overgrowth directly. The first-line pharmaceutical approach is rifaximin, 550 mg three times daily for 14 days, which has a roughly 44% response rate in clinical trials (Pimentel et al. 2011, TARGET 3 trial). For methane-dominant SIBO (IMO), rifaximin is combined with neomycin (500 mg twice daily) or metronidazole. Herbal antimicrobial protocols using combinations of berberine, oregano oil, neem, and allicin have shown comparable efficacy to rifaximin in at least one study (Chedid et al. 2014). After eradication, prokinetic therapy (low-dose erythromycin, prucalopride, or low-dose naltrexone) is often used to restore MMC function and prevent relapse.
â ī¸Do not self-treat with antibiotics or herbal antimicrobials based on symptom suspicion alone. Get tested first. Treatment without diagnosis can mask other conditions, create antibiotic resistance, and disrupt your large intestinal microbiome unnecessarily.
Can you have both IBS and SIBO at the same time?
Yes, and this is common. SIBO can be the underlying cause of IBS symptoms, or it can coexist with IBS that has additional contributing factors like visceral hypersensitivity, altered gut-brain signaling, or psychological stress. Treating the SIBO component may resolve symptoms entirely in some patients or significantly reduce symptom burden while leaving a residual IBS component that requires separate management. The Pimentel group's research suggests that in many cases, what is diagnosed as IBS is actually SIBO that has never been tested for. The 60-78% overlap figure from the Pimentel 2000 and Lin 2004 studies supports this interpretation, though the exact proportion varies by study and diagnostic method used.
Frequently Asked Questions
Can IBS turn into SIBO?
IBS itself does not transform into SIBO. However, the motility problems that contribute to IBS, particularly a dysfunctional migrating motor complex, create conditions that allow SIBO to develop. Medications used for IBS (like opioids for pain or anticholinergics) can also slow motility enough to promote bacterial overgrowth. Many patients diagnosed with IBS likely had undetected SIBO from the start.
Should every IBS patient be tested for SIBO?
This remains debated. Current ACG guidelines do not recommend routine SIBO testing for all IBS patients. However, many SIBO specialists argue that testing is warranted given the high overlap. At minimum, patients with IBS who are not responding to standard treatments, who have a post-food-poisoning onset, or who report symptoms strongly tied to meals should be tested.
If I test positive for SIBO, does that mean I do not have IBS?
Not necessarily. A positive SIBO test means you have bacterial overgrowth that may be causing or contributing to your symptoms. Some patients find that treating SIBO resolves their IBS symptoms completely. Others still meet IBS criteria after SIBO treatment, suggesting both conditions are present. SIBO treatment is still worthwhile because it addresses a treatable component of your symptoms.
How long does it take to get a SIBO breath test?
The test itself takes 2-3 hours (depending on whether glucose or lactulose substrate is used). You need 24 hours of dietary preparation beforehand and a 12-hour fast. At-home kits like trio-smart can be ordered by your physician and completed at home, with results typically returned within 5-7 business days. In-office testing provides same-day results at some clinics.
Is SIBO curable while IBS is not?
SIBO can be eradicated with antibiotics or herbal antimicrobials, but it recurs in roughly 44% of patients within 9 months if the underlying cause (impaired motility, structural issues, or medication effects) is not addressed. IBS is considered a chronic condition managed rather than cured. When SIBO is the primary driver of IBS symptoms, treating the SIBO and maintaining motility with prokinetics can produce lasting remission.
â ī¸This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.